PremiumCompany AnnouncementsLisata Therapeutics’ Earnings Call: Progress Amid Challenges Lisata Therapeutics Reports 2024 Financial Results and Updates Lisata Therapeutics exploring certepetide’s versatility in non-cancerous setting PremiumThe FlyLisata, WARPNINE announces preliminary results from Phase 1b/2 iLSTA trial Lisata Therapeutics reports preliminary Cohort A data from Phase 2 ASCEND trial Lisata Therapeutics complete enrollment in CENDIFOX trial PremiumThe FlyLisata Therapeutics, Valo Therapeutics enter preclinical research collaboration LSTA Earnings this Week: How Will it Perform? Lisata Therapeutics entered research agreement with University of Cincinnati